Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
vaccine (KINRIX) valid for this patient (two year old; intended vaccine was INFANRIX.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-year-old male patient who received DTPa-IPV (Kinrix) for prophylaxis. On 15-MAY-2024, the patient received Kinrix. On 15-MAY-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: vaccine (KINRIX) valid for this patient (two year old) and inappropriate schedule of vaccine administered (Verbatim: intended vaccine was INFANRIX.). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-AUG-2025 The medical assistant called asking was that Kinrix vaccine valid for this patient of two year old. The intended vaccine was Infanrix which led to inappropriate schedule of vaccine administered and inappropriate age at vaccine administration. No vaccine detail was obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.